Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD

Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents

(2016) Jordan Axelrad et al.   Clinical Gastroenterology and Hepatology

PTH-081 Allopurinol Abrogates Thiopurine Induced Liver Injury Without The Need for Metabolite Measurments

(2016) P Pavlidis et al.   GUT

Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease

(2016) Polychronis Pavlidis et al.   INFLAMMATORY BOWEL DISEASES

Thiopurine metabolite testing in inflammatory bowel disease

(2016) Rimma Goldberg et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Update 2014

(2015) Jaimin Amin et al.   INFLAMMATORY BOWEL DISEASES

Disease Activity Assessment in IBD

(2015) James D. Falvey et al.   INFLAMMATORY BOWEL DISEASES

Optimizing the use of thiopurines in inflammatory bowel disease

(2015) Rishi M. Goel et al.   Therapeutic Advances in Chronic Disease

Association Between 6-Thioguanine Nucleotides Levels and Clinical Remission in Inflammatory Disease

(2014) Amelie Carla Moreau et al.   INFLAMMATORY BOWEL DISEASES

Thiopurine Metabolite Ratios for Monitoring Therapy in Pediatric Crohn Disease

(2014) U. Kopylov et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Long-term Outcome of Patients With Crohn's Disease Who Respond to Azathioprine

(2012) Marine Camus et al.   Clinical Gastroenterology and Hepatology

Mucosal healing in inflammatory bowel diseases: a systematic review

(2012) Markus F Neurath et al.   GUT

Safety and Effectiveness of Long-term Allopurinol–Thiopurine Maintenance Treatment in Inflammatory Bowel Disease

(2012) Frank Hoentjen et al.   INFLAMMATORY BOWEL DISEASES

Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol

(2012) Melissa A. Smith et al.   Journal of Crohns & Colitis

A skewed thiopurine metabolism is a common clinical phenomenon that can be successfully managed with a combination of low-dose azathioprine and allopurinol

(2012) Malin Lindqvist Appell et al.   Journal of Crohns & Colitis

Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

(2011) Khurram J Khan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy

(2011) Natalia López-Palacios et al.   European Journal of Internal Medicine

Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease

(2011) Laurent Peyrin–Biroulet et al.   GASTROENTEROLOGY

Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease

(2010) A. ANSARI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity

(2010) Severine Vermeire et al.   Clinical Gastroenterology and Hepatology

A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease

(2010) David S. Kotlyar et al.   Clinical Gastroenterology and Hepatology

A prospective evaluation of the impact of allopurinol in pediatric and adult IBD patients with preferential metabolism of 6-mercaptopurine to 6-methylmercaptopurine

(2010) Mark E. Gerich et al.   Journal of Crohns & Colitis

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease

(2009) Yvette Leung et al.   Journal of Crohns & Colitis

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

(2009) Laurent Beaugerie et al.   LANCET

Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease

(2008) A. ANSARI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease

(2008) Riad M. Rahhal et al.   INFLAMMATORY BOWEL DISEASES

Azathioprine Is Superior to Budesonide in Achieving and Maintaining Mucosal Healing and Histologic Remission in Steroid-Dependent Crohnʼs Disease

(2008) Gerassimos J. Mantzaris et al.   INFLAMMATORY BOWEL DISEASES